Q32 Bio Inc. — Net Income by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/0c581ee6-c804-4b17-9a9b-56209781843e/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $29.8M | 2025-01-01 – 2025-12-31 | evidence 0001193125-26-193934 |
| FY 2024 | $-47.7M | 2024-01-01 – 2024-12-31 | evidence 0001193125-26-193934 |
| FY 2023 | $-53.7M | 2023-01-01 – 2023-12-31 | evidence 0001193125-26-193934 |
| FY 2022 | $-5.0M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-006995 |
| FY 2021 | $-95.8M | 2021-01-01 – 2021-12-31 | evidence 0000950170-22-004401 |
| FY 2020 | $-128.7M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-012490 |
| FY 2019 | $-103.9M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-010441 |
| FY 2018 | $-55.6M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-018819 |
| FY 2017 | $-30.0M | 2017-01-01 – 2017-12-31 | evidence 0001564590-19-007250 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).